endocarditis
Information
- Disease name
- endocarditis
- Disease ID
- DOID:10314
- Description
- "A endocardium disease characterized by inflammation of the endocardium of the heart chambers and valves." [url:http\://en.wikipedia.org/wiki/Endocarditis, url:http\://www.nhlbi.nih.gov/health/health-topics/topics/endo/]
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
Genes | Mutation | Description | Source | Links |
---|
NCT ID | Status | Phase | Summary | Start date | Completion date |
---|---|---|---|---|---|
NCT06434012 | Active, not recruiting | Barts Endocarditis Research Registry | April 24, 2019 | April 30, 2029 | |
NCT00548002 | Completed | Combination Therapy With Fluoroquinolone in Staphylococcus Aureus Bacteremia | January 1999 | August 2002 | |
NCT03695861 | Completed | N/A | Contribution of 18F-FDG PET-CT in the Diagnosis and the Detection of Peripheral Emboli of Infectious Endocarditis on Native Valves | November 10, 2018 | September 16, 2020 |
NCT04309591 | Completed | Cytosorb Therapy in Cardiac Surgery | October 18, 2019 | December 4, 2019 | |
NCT04068337 | Completed | Freestyle Prosthesis for Aortic Root-replacement With and Without Hemiarch Replacement | August 1, 2018 | August 1, 2019 | |
NCT03377465 | Completed | N/A | Biomarkers, Hemodynamic and Echocardiographic Predictors of Ischemic Strokes and Their Influence on the Course and Prognosis | November 15, 2016 | December 5, 2017 |
NCT00709358 | Completed | Phase 4 | Diagnosis of Septicaemia by Detection of Microbial DNA in Blood in Severe Infections | May 2008 | September 2010 |
NCT00750373 | Completed | Phase 4 | Early Surgery Versus Conventional Treatment in Infective Endocarditis | September 2006 | September 2011 |
NCT00166023 | Completed | Outcomes Following Medical or Surgical Management of Endocarditis | August 2005 | December 2006 | |
NCT01375257 | Completed | Phase 4 | Partial Oral Treatment of Endocarditis | July 2011 | August 30, 2017 |
NCT01431326 | Completed | Pharmacokinetics of Understudied Drugs Administered to Children Per Standard of Care | November 2011 | November 2019 | |
NCT05474118 | Completed | Real-life Use of Cefazolin for the Treatment of Meticillin-susceptible Staphylococcal Infective Endocarditis: Comparison to a Treatment Cohort With Penicillin M | February 5, 2020 | March 31, 2022 | |
NCT02026895 | Completed | N/A | Virulence of Staphylococcus Lugdunensis in Severe Infections | December 2013 | February 2016 |
NCT02251262 | Completed | N/A | Diagnostic Accuracy of 18FDG-PET-CT for Pacing or Defibrillation Lead Infection | June 22, 2015 | June 19, 2018 |
NCT04387513 | Completed | Impact of Early Cardiac Surgery in Severe Left Endocarditis With Neurological Complications: a Retrospective Study | August 1, 2010 | December 31, 2017 | |
NCT05156437 | Enrolling by invitation | Phase 4 | Postoperative Antibiotic Management Duration Following Surgery for Intravenous Drug Abuse (IVDA) Endocarditis (OPTIMAL) | March 16, 2022 | October 2024 |
NCT06422221 | Not yet recruiting | Phase 4 | An Oral Doxycycline Regimen to Prevent Bacteremia Following Dental Procedures | July 15, 2024 | June 30, 2025 |
NCT05613933 | Not yet recruiting | N/A | Effectiveness of Antibiotic Prophylaxis of Infective Endocarditis for Invasive Dental Procedures in Patients With Prosthetic Heart Valves and/or History of Infective Endocarditis | February 1, 2023 | December 31, 2027 |
NCT06107309 | Recruiting | Suppressive Antibiotic Therapy for Endocarditis | March 1, 2023 | March 2024 | |
NCT03718052 | Recruiting | N/A | Early Valve Surgery Versus Conventional Treatment in Infective Endocarditis Patients With High Risk of Embolism | April 11, 2019 | April 11, 2026 |
NCT03892174 | Recruiting | N/A | Cytokine REmoval in CRitically Ill pAtients Requiring Surgical Therapy for Infective Endocarditis (RECReATE) | November 14, 2019 | December 1, 2024 |
NCT05139589 | Recruiting | The ENDOCARDITIS AUMC Data Collection | August 6, 2023 | December 31, 2030 | |
NCT05144399 | Recruiting | Phase 4 | Accelerated Treatment of Endocarditis | April 1, 2019 | December 31, 2026 |
NCT05146180 | Recruiting | N/A | Interest of Parametric Positron Emission Imaging in the Diagnosis of Infections on Cardiac Valve Prosthesis | February 24, 2022 | March 1, 2024 |
NCT05378126 | Recruiting | N/A | Evaluation of the Prognostic Impact of a Neuro-vascular Examination Associated With Cerebral MRI in the Acute Phase of Infectious Endocarditis | April 6, 2023 | July 2025 |
NCT05432427 | Recruiting | N/A | 64Cu-DOTATATE PET-CT-skanning and Infective Endocarditis. | April 28, 2022 | June 1, 2025 |
NCT05547607 | Recruiting | Clinical and Diagnostic Features of Endocarditis | September 9, 2022 | September 30, 2025 | |
NCT05703022 | Recruiting | N/A | Early Exercise Training in Patients Following Heart Valve Surgery for Infective Endocarditis. | November 30, 2021 | June 30, 2025 |
NCT06275100 | Recruiting | N/A | PREhabilitation in Patients Awaiting Acute Inpatient Cardiac SurgEry | April 3, 2024 | June 2025 |
NCT06330766 | Recruiting | Impact of Preoperative Dental Screening in Reducing Infective Endocarditis Risk in Transcatheter Aortic Valve Implantation Patients | January 1, 2020 | January 1, 2026 | |
NCT06403839 | Recruiting | Impact of Preoperative Dental Screening in Reducing Infective Endocarditis Risk in Surgical Valve Replacement Patients | January 1, 2020 | March 1, 2028 | |
NCT03148756 | Terminated | Phase 2 | Efficacy and Safety of Dalbavancin Compared to Standard of Care Antibiotic Therapy for the Completion of Treatment of Patients With Complicated Bacteremia or Infective Endocarditis | May 12, 2017 | August 4, 2017 |
NCT03411499 | Terminated | N/A | Stroke-free Survival Comparison Between Early Surgery and Conventional Therapy in Left Infective Endocarditis | December 22, 2017 | December 14, 2020 |
NCT00590889 | Terminated | N/A | Artificial Valve Endocarditis Reduction Trial | July 1998 | September 2014 |
NCT00995384 | Terminated | N/A | Cardiac Computed Tomography (CT) Scan Compared to Transesophageal Echocardiogram (TEE) in Endocarditis | October 2009 | October 2010 |
NCT02783404 | Terminated | Phase 4 | An Oral Amoxicillin-Clavulanate Regimen to Prevent Bacteremia Following Dental Procedures | February 27, 2017 | May 17, 2022 |
NCT01734694 | Terminated | Phase 4 | Safety and Efficacy of Strategy to Prevent Drug-Induced Nephrotoxicity in High-Risk Patients | October 2011 | September 2012 |
NCT02459613 | Terminated | Phase 1/Phase 2 | Assessment of Radiolabeled rhAnnexin V-128 in Infective Endocarditis | February 5, 2016 | May 2017 |
NCT02759978 | Unknown status | Individualized Diagnosis of Endocarditis and Its Therapy With a Focus on Infected Prosthetic materiAL | May 2016 | May 2023 | |
NCT03690076 | Unknown status | Human Cardiac Mitochondria in Acute Endocarditis and Obesity | October 9, 2018 | September 30, 2020 | |
NCT01301638 | Unknown status | Retrospective Evaluation of Safety and Efficacy of Daptomycin Used in Patients With Serious Gram-positive Infections | February 2011 | ||
NCT02443064 | Unknown status | Phase 4 | Pharmacokinetics/ Pharmacodynamics (PK/PD) Study of Vancomycin | January 2014 | June 2016 |
NCT03231449 | Unknown status | A Survey of Hospitalizations in Cardiology Units in Sub-Saharan Africa | February 1, 2017 | February 2021 | |
NCT03429153 | Unknown status | Management of Infectious Endocarditis as Part of a Multidisciplinary Consensus Meeting | January 5, 2018 | August 2018 | |
NCT05142891 | Unknown status | Renal Tolerance of Amoxicillin and Cloxacillin Combination | October 15, 2021 | October 30, 2022 | |
NCT03112356 | Unknown status | Phase 4 | The Value of 99mTc-Leukoscan® Scintigraphy in the Diagnosis of Infectious Endocarditis on Surgical Materials | June 14, 2017 | October 14, 2018 |
NCT00579761 | Withdrawn | Retrospective Review of Management of Infective Endocarditis |
- Disase is a (Disease Ontology)
- DOID:0050825
- Cross Reference ID (Disease Ontology)
- ICD10CM:I33.9
- Cross Reference ID (Disease Ontology)
- ICD9CM:421.9
- Cross Reference ID (Disease Ontology)
- MESH:D004696
- Cross Reference ID (Disease Ontology)
- NCI:C34582
- Cross Reference ID (Disease Ontology)
- NCI:C35432
- Cross Reference ID (Disease Ontology)
- SNOMEDCT_US_2023_03_01:56819008
- Cross Reference ID (Disease Ontology)
- SNOMEDCT_US_2023_03_01:91357005
- Cross Reference ID (Disease Ontology)
- UMLS_CUI:C0014118
- Cross Reference ID (Disease Ontology)
- UMLS_CUI:C0375268
- HPO Human Phenotype ID (Human Phenotype Ontology)
- HP:0100584
- MedGen unique identifier (MedGen Concept name)
- 4940
- MedGen concept unique identifier (MedGen Concept name)
- C0014118
- MeSH unique ID (MeSH (Medical Subject Headings))
- D004696